No Detail Found!

Defining the best time to initiate therapy and treatment goals in negative culture mycetoma: A case from a non-endemic country

Author(s)
Teguh Hopkop Putera Manurung Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia–dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia.
Farah Faulin Al Fauz Lubis Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia–dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia.
Adhika Ayu Lestari Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia–dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia
Sondang Pandjaitan Sirait, Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia–dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia
Sandra Widaty Department of Dermatology and Venereology, Faculty of Medicine, Universitas Indonesia–dr. Cipto Mangunkusumo National Central General Hospital, Jakarta, Indonesia.
Abstract
Mycetoma is a chronic granulomatous suppurative disease of the skin and underlying tissue caused by saprophytic fungus (eumycetoma) or actinomycetes (actinomycetoma). Despite having a low prevalence and low mortality rate, mycetoma may cause serious complications such as deformity and disability due to destruction of skin and adjacent structures. Various therapeutic options call for a thorough diagnostic approach before initiating therapy. Prompt treatment is imperative to limit disabilities. Furthermore, mycetoma is prone to recurrences, hence rigorous assessment of therapeutic goal is essential. We reported a case of actinomycetoma confirmed by histopathology examination and successfully treated with combination of rifampicin and cotrimoxazole.
Publication Details
Page(s) 290-295
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 34, Issue: 1, Year: 2024

Request the full text from PASTIC

Keywords
mycetoma, Negative culture, Non-endemic country.
References
Bramono Kusmarinah,Bramono K,Suyoso S,Widaty S,Ramali LM,Siswati AS,Ervianti AV .2019 .. Mikosis Profunda, : 53-65.
Reis CMS,Reis-Filho EG de M. CMS .2018 .Mycetomas: an epidemiological, etiological, clinical, laboratory and therapeutic review. , 93 : 8-18.
. .Neglected tropical diseases [Internet]. WHO. [cited 2023 Feb, 19 : .
Miranda Eliza,Bramono K,Suyoso S,Widaty S,Ramali LM,Siswati AS,Ervianti AV .2019 .. Mikosis Profunda, : 41-52.
Relhan V,Mahajan K,Agarwal P,Garg VK .2017 .Mycetoma: an update. Indian J Dermatol, 62(4) : 332.
Suyoso S,Ervianti AV,Astari L,Anggraeni S,Widia Y.,Pendahuluan Y.,Bramono K,Widaty S,Ramali LM,Siswati AS,Ervianti AV .2019 .: mikosis profunda. Mikosis Profunda, : 53-65.
Yahya S,Widaty S,Miranda E,Bramono K,Islami AW .2016 .Subcutaneous mycosis at the department of dermatology and venereology dr. J Gen Proc Dermatol Venereol Indonesia, 1(2) : 1.
Efared B,Tahiri L,Boubacar MS,AtsamEbang G,Hammas N,Hinde EF .2017 .Mycetoma in a non-endemic area: a diagnostic challenge. BMC Clin Pathol, 17(1) : 1-6.
Zeeshan M,Fatima S,Farooqi J,Jabeen K,Ahmed A,Haq A .2022 .Reporting of mycetoma cases from skin and soft tissue biopsies over a period of ten years: A single center report and literature review from Pakistan. PLoS Neg Trop Dis, 16(7) : e0010607.
Bakshi R,Mathur DR .2008 .Incidence and changing pattern of mycetoma in western Rajasthan. Indian J Pathol Microbiol, 51(1) : 154.
Argentina F,Karim PL .2022 .. Extensive Actinomycetoma Clinical Manifestations and Histopathology: A Case Report. Bioscientia Medicina: J Biomed Transl Res, 6(15) : 2705-12.
Liu A,Maender JL,Coleman N,Hsu S,Rosen T. .2008 .Actinomycetoma with negative culture: a therapeutic challenge. Dermatol Online J, 14(4) : .
Bravo FG,Arenas R,Sigall DA,Amagai M,Bruckner AL,Enk AH,Margolis DJ,McMichael AJ .2019 .Actinomycosis, nocardiosis, and actinomycetoma. Fitzpatrik's Dermatology, : 2876-91.
Sampaio FMS,Wanke B,Freitas DFS,Coelho JMC DFS,Galhardo MCG,Lyra MR .2017 .. PLoS Neg Trop Dis, 11(2) : 1-18.
Patra S,Senthilnathan G,Ramam M,Arava S,Bhari N.,Linezolid N. .2021 .A novel treatment option for the treatment of a non-responsive case of actinomycotic mycetoma. Indian J Dermatol Venereol Leprol, 87(3) : 473-5.
Husain U,Verma P,Suvirya S,Priyadarshi K,Gupta P. .2023 .An overview of mycetoma and its diagnostic dilemma: time to move on to advanced techniques. Indian J Dermatol Venereol Leprol, 89(1) : 12-7.
Hao X,Cognetti M,Burch-Smith R,Mejia EO,Mirkin G .2022 .Mycetoma: Development of Diagnosis and Treatment. J Fungi, 8(7) : 743.
.2013 .Global burden of human mycetoma: a systematic review and metaanalysis. PLoS Neg Trop Dis, 7(11) : e2550.
Fahal A,Mahgoub ES,Hassan AME,Abdel-Rahman ME .2015 .Mycetoma in the Sudan: an update from the mycetoma research centre. PLoS Neg Top Dis, 9(3) : e0003679.
0

Citations

0

Downloads

63

Views